WELL Historical Cash Flow
| WELL Stock | CAD 5.20 0.03 0.58% |
Analysis of WELL Health cash flow over time is an excellent tool to project WELL Health Technologies future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Stock Based Compensation of 27.5 M or Free Cash Flow of 39.1 M as it is a great indicator of WELL Health ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining WELL Health Technologies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether WELL Health Technologies is a good buy for the upcoming year.
WELL |
About WELL Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in WELL balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which WELL's non-liquid assets can be easily converted into cash.
WELL Health Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from WELL Health's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into WELL Health Technologies current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in WELL Health Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, WELL Health's Total Cash From Financing Activities is very stable compared to the past year. As of the 26th of November 2024, Change To Inventory is likely to grow to about 199.5 K, though Change In Cash is likely to grow to (5.2 M).
WELL Health cash flow statement Correlations
Click cells to compare fundamentals
WELL Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
WELL Health cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 13.3M | 71.2M | (25.0M) | (13.0M) | (5.5M) | (5.2M) | |
| Stock Based Compensation | 2.9M | 5.0M | 21.0M | 24.5M | 26.2M | 27.5M | |
| Free Cash Flow | (3.1M) | (6.5M) | 19.6M | 70.1M | 37.2M | 39.1M | |
| Change In Working Capital | 321.7K | (1.9M) | (11.2M) | (6.1M) | (10.2M) | (9.7M) | |
| Begin Period Cash Flow | 2.3M | 15.6M | 86.9M | 61.9M | 48.9M | 51.4M | |
| Capital Expenditures | 472.4K | 1.1M | 2.7M | 6.4M | 25.4M | 26.7M | |
| Total Cash From Operating Activities | (2.6M) | (5.4M) | 22.3M | 76.5M | 62.6M | 65.7M | |
| Net Income | (7.8M) | (3.2M) | (30.9M) | 18.7M | 82K | 86.1K | |
| End Period Cash Flow | 15.6M | 86.9M | 61.9M | 48.9M | 43.4M | 24.3M | |
| Other Cashflows From Financing Activities | 26.0M | 5.6M | 191.2M | 21.1M | (25.1M) | (23.8M) | |
| Total Cash From Financing Activities | 26.6M | 120.8M | 452.5M | (52.8M) | 39.6M | 66.1M | |
| Total Cashflows From Investing Activities | (10.7M) | (44.2M) | (499.8M) | (37.9M) | (34.1M) | (35.8M) | |
| Depreciation | 2.2M | 4.3M | 38.2M | 55.2M | 60.8M | 63.8M | |
| Other Non Cash Items | 1.3M | (4.6M) | 4.1M | (14.8M) | (3.8M) | (3.6M) | |
| Change To Account Receivables | (677.6K) | (3.2M) | (13.3M) | (9.4M) | (2.5M) | (2.6M) | |
| Other Cashflows From Investing Activities | 90.4K | (4.5M) | (25.5M) | (31.5M) | (28.4M) | (27.0M) | |
| Sale Purchase Of Stock | 12.5M | 19.0M | 119.1M | 303.1M | (243K) | 0.0 | |
| Investments | (10.7M) | (44.2M) | (3.1M) | (37.9M) | (81.3M) | (77.2M) | |
| Change To Operating Activities | 162.2K | (951.7K) | 209K | (6.7M) | (6.1M) | (5.8M) | |
| Change To Netincome | 763.2K | 2.6M | (4.2M) | 37.9M | 43.5M | 45.7M | |
| Change To Liabilities | 920.5K | 2.3M | 1.2M | 10.1M | 11.7M | 12.2M |
Other Information on Investing in WELL Stock
The Cash Flow Statement is a financial statement that shows how changes in WELL balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which WELL's non-liquid assets can be easily converted into cash.